Created in 1997 (United States), Keryx Biopharmaceuticals own 4 sister brands and 2214 competing brands. The Keryx Biopharmaceuticals brand is owned by Akebia Therapeutics, a company listed in New York. The sector of Keryx Biopharmaceuticals is Biotechnology.